Sign Up Today and Learn More About Resolution Therapeutics Stock
Invest in or calculate the value of your shares in Resolution Therapeutics or other pre-IPO companies through EquityZen's platform.
Resolution Therapeutics Stock
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
About Resolution Therapeutics Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
Resolution Therapeutics Press Mentions
Stay in the know about the latest news on Resolution Therapeutics
Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain
prnewswire • Nov 20, 2024
Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain
pharmiweb • Nov 20, 2024
Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain
prnewswire • Nov 19, 2024
Regenerative macrophage therapy demonstrates potential in liver disease
longevity • Nov 12, 2024
Syncona makes further investment in Resolution Therapeutics
marketscreener • Oct 05, 2024
Resolution Therapeutics Management
Leadership team at Resolution Therapeutics
CEO
Amir Hefni
CFO
Simon Ramsden
Join now and verify your accreditation status to gain access to:
- Resolution Therapeutics current valuation
- Resolution Therapeutics stock price
- Available deals in Resolution Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Resolution Therapeutics Stock
How to invest in Resolution Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Resolution Therapeutics through EquityZen funds. These investments are made available by existing Resolution Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Resolution Therapeutics stock?
Shareholders can sell their Resolution Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
